Clinical Trial Update: Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating atezolizumab with etoposide and platinum chemotherapy for small cell bladder cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Small Cell Carcinoma of the Bladder
• Urothelial Carcinoma of the Bladder

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer | Phase 2 | Status: RECRUITING